Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Current Assets (2016 - 2025)

International Stem Cell (ISCO) has disclosed Current Assets for 16 consecutive years, with $3.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets rose 6.99% to $3.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $3.7 million, a 6.99% increase, with the full-year FY2024 number at $3.6 million, up 1.11% from a year prior.
  • Current Assets was $3.7 million for Q3 2025 at International Stem Cell, down from $3.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $3.8 million in Q2 2025 to a low of $2.3 million in Q4 2021.
  • A 5-year average of $3.3 million and a median of $3.5 million in 2024 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: fell 18.01% in 2021, then soared 35.48% in 2023.
  • International Stem Cell's Current Assets stood at $2.3 million in 2021, then grew by 26.95% to $3.0 million in 2022, then grew by 18.83% to $3.5 million in 2023, then rose by 1.11% to $3.6 million in 2024, then rose by 4.89% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Current Assets are $3.7 million (Q3 2025), $3.8 million (Q2 2025), and $3.8 million (Q1 2025).